CD4 and neoplasm: Ongoing research explores the significance of MHC-II expression on tumor cells, current evidence indicates that it enables the direct presentation of tumor neoantigens to CD4+ T helper cells and is linked to improved outcomes in surgically removed lung adenocarcinomas.